PTEN and cancer: Quantitative RNA (q-PCR) measurement of mAR-Va, b, and c confirmed the elevation of isoforms in hormone intact and CRPC Pten deficient cancers with respect to Wt prostates and normalized to AR-FL (Fig 2d) (**, p<0.01).